Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Lawyers suing Bayer over the popular birth control pills Yaz and Yasmin have convinced Multi District Judge David Herndon to revise a previously negotiated privacy ruling in their favor. The new ruling, handed down on Sept. 22, prohibited the drug company from editing sales strategy information about contraceptives similar to Yaz and Yasmin in documents that it was required to deliver to plaintiffs. Workers must now pore through more than 30 million pages of information, find each redaction, and determine the reason why the document was altered.

Read the rest of this entry »

Watson Pharmaceuticals has received approval from the Food and Drug Administration (FDA) under the Abbreviated New Drug Application for Zarah, its new oral contraceptive pill that serves as a generic version of Bayer’s best-selling birth control pill Yasmin. Yasmin and its generic equivalents sold approximately $97 million in the U.S. for the twelve months ending June 30, 2010.

Read the rest of this entry »

Twenty-five California women have joined more than a thousand others across the country in a lawsuit against Bayer HealthCare claiming the company’s blockbuster birth control pills – Yaz and Yasmin – caused them to suffer life threatening health problems such as strokes and blood clots. The defendants say the company was aware its oral contraceptives increased a woman’s chances of serious health problems even more than other birth control pills, yet the company failed to adequately warn women of that risk.

Read the rest of this entry »

Dawn Varrechio, a mother of four, was shocked to discover that her breathing problems were due to blood clots in both of her lungs. But she became angry when she found out her birth control pills were the culprit. “It’s scary to think that at 35, you could be gone, like that quickly,” she told CBS3 News.

Read the rest of this entry »

As Bayer HealthCare begins defending itself against a flurry of lawsuits citing health problems over its blockbuster birth control pills Yaz and Yasmin, the drug company announced it has received approval from the Food and Drug Administration (FDA) on a new oral contraceptive. Bayer’s Natazia combines the hormones estrogen and progestin in doses that adjust four times throughout a women’s menstruation cycle. Natazia is the first birth control pill to use the four-phase dosing protocol with the added benefit of controlling irregular bleeding better than other pills.

Read the rest of this entry »

Even before Bayer Healthcare agreed to change the label on its No. 1 selling birth control pills, Yaz and Yasmin, to include an elevated risk of blood clots and other health problems, a citizen’s right advocacy group placed the oral contraceptive on its “Do Not Use” list. The move by Public Citizen was in direct response to the mounting lawsuits filed against the company alleging the pills caused high potassium levels that can cause the heart to slow down and allow life-threatening blood clots to form.

Read the rest of this entry »

Bayer HealthCare has added new information on the labels of its blockbuster birth control pills Yaz and Yasmin to warn users that the risk of developing blood clots while taking the pills are similar to the risks with other oral contraceptives. The label change comes on the heels of hundreds of lawsuits filed both in the United States and Canada by women who say they were injured by Yaz or Yasmin but were not adequately warned of the risks associated with taking the pills. Bayer agreed to make the changes to the pills’ labels based on two large, multiyear studies of more than 120,000 women taking contraceptives in the U.S. and the U.K.

Read the rest of this entry »

Despina Papparis says her daughter Chloe is alive by “sheer luck.” The Canadian teenager, now 18, was rushed to the hospital after suffering from bad migraines and vomiting that was originally thought to be symptoms of the swine flu. But an emergency room doctor ordered a CT scan that found five blood clots in her brain. Doctors said if she had she waited one more day to seek treatment, she would have died. But it was what they said caused the malady that took the Papparises by surprise. They said her birth control pills were to blame.

Read the rest of this entry »

Bayer Schering Pharma has announced it will update the label in the European market for its oral contraceptive Yasmin, a combination of ethinylestradiol and the diuretic drospirenone, also known by the brand name Yaz and the generic brand Ocella. The new label will include results of four epidemiological studies conducted by independent investigators that show the risk for venous thromboembolism, or blood clots, in Yasmin users is comparable to the risk found for women who use levonorgestrel-containing oral contraceptives.

Read the rest of this entry »

Monica Dakin lost a year of her life because of her birth control pills.

The 23-year-old Canadian was prescribed the popular oral contraceptive Yaz last May to treat her ovarian cysts. She believed the low-dose hormone carried fewer side effects than other birth control pills. But soon after starting the medication, she was doubled over with abdominal pain. Dakin was hospitalized six times in the first six months before surgeons finally removed her gallbladder in an emergency procedure.

Read the rest of this entry »